| Pemetrexed n = 441) | Placebo (n = 222) | HR (95% CI) | P Value |
---|---|---|---|---|
Overall Median PFS, months | 4.0 | 2.0 | 0.60 (0.49-0.73) | < 0.0001 |
Median PFS in Nonsquamous cases (n = 481) | 4.4 | 1.8 | 0.47 (0.37-0.60) | < 0.00001 |
Median PFS in Squamous cases (n = 182) | 2.4 | 2.5 | 1.03 (0.77-1.50) | Not Significant |
Overall Median OS, months | 13.4 | 10.6 | 0.79 (0.65-0.95) | 0.012 |
Overall Median in Nonsquamous cases (n = 481) | 15.5 | 10.3 | 0.70 (0.56-0.88) | 0.002 |
Overall Median in Squamous cases (n = 182) | 9.9 | 10.8 | 1.07 (0.49-0.73) | Not Significant |